NICE’s beat, raise of last quarter is a testament to its strong technological foundations. But see why we remain in a wait-and-watch mode on NICE stock.
NICE (Nasdaq: NICE) today announced that Gartner has recognized NICE as a Leader in the just-released 2022 Gartner Magic Quadrant for Contact Center as a Service (CCaaS) report with CXone being evaluated. NICE placed the furthest overall for its Completeness of Vision in the Leaders quadrant. This marks the eighth consecutive year that NICE has been named a Leader in the CCaaS Magic Quadrant.
Nice Ltd (NASDAQ:NASDAQ:NICE) Q2 2022 Results Earnings Conference Call August 18, 2022, 08:30 AM ET Company Participants Marty Cohen - Vice President, Investor Relations Barak Eilam - Chief…
Shares of cloud and on-premises enterprise software solutions provider NICE Ltd. (NICE) are in the green in today''s pre-market trading on the back of its robust Q2 showing, marked by margin expansion and upbeat guidance. On the back of a 27.9% jump in cloud revenue, total non-GAAP revenue increased 15.6% year-over-year to $530.6 million, outperforming expectations by $5.5 million. EPS of $1.86, too, beat the consensus by $0.07. The company had generated an EPS of $1.57 in the comparable year-ago period. Additionally, while its total gross margin expanded to 73.3% from 72.2% a year ago, the operating margin increased to 29% from 28.2% a year ago.
The following slide deck was published by NICE Ltd. in conjunction with their 2022 Q2 earnings call.
NICE should see plenty of growth medium to longer term. Though NICE stock trades at a warranted premium valuation, see why I think it''s a BUY.
HOBOKEN, N.J.--(BUSINESS WIRE)-- #NICE--NICE (Nasdaq: NICE) today announced that the 2022 National Technology Awards, sponsored by National Technology News, named NICE Enlighten AI as its “Customer Experience Technology of the Year ” award winner. In its sixth year, the awards program is a comprehensive celebration of leading technology across a range of industries and organized by National Technology News, part of Perspective Publishing, a leading publishing and events company. The customer experience
HOBOKEN, N.J.--(BUSINESS WIRE)-- #NICE--NICE Actimize, a NICE (NASDAQ: NICE) business, today confirmed that American State Bank, a Texas-based financial institution, has selected NICE Actimize Xceed, an all-in-one AI fraud and anti-money laundering platform, to drive the financial institution’s restructured financial crime strategy. Powered by the cloud and always-on AI, NICE Actimize’s Xceed provides best-in-class AML, fraud and case management in a single risk platform. From real-time onboarding thro
NICE Actimize, a NICE (NASDAQ: NICE) business, has been ranked by global advisory and consulting firm Quadrant Knowledge Solutions as a top performing Know Your Customer/Customer Due Diligence (KYC/CDD) Technology Leader in its recently released “SPARK Matrix: Know Your Customer (KYC) Solution, 2022” report. The Quadrant Knowledge Solutions study, which provides competitive analysis and a ranking
Nice Ltd (NASDAQ:NASDAQ:NICE) Q1 2022 Earnings Conference Call May 12, 2022, 08:30 ET Company Participants Marty Cohen - IR Barak Eilam - CEO Beth Gaspich - CFO Conference Call Participants…
The following slide deck was published by NICE Ltd. in conjunction with their 2022 Q1 earnings call.
NICE (NASDAQ: NICE ) reported its Q1 earnings results on Thursday, May 12, 2022 at 05:30 AM. Here''s what investors need to know about the announcement. Earnings NICE beat estimated earnings by 5.26%, reporting an EPS of $1.8 versus an … Full story available on Benzinga.com
NICE Ltd (NASDAQ: NICE ) reported first-quarter FY22 non-GAAP revenue growth of 15.4% year on year to $527.4 million, beating the consensus of $510.8 million. Non-GAAP revenues from Cloud grew 28.1% Y/Y to $295 million. Non-GAAP gross margin expanded 30 bps to 73%, while the non-GAAP operating margin expanded 10 bps to 28.3%. Non-GAAP EPS of $1.80 beat … Full story available on Benzinga.com
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ: REFI ) is projected to report earnings for its first quarter. • Archer Aviation (NYSE: ACHR ) is likely to report earnings for its first quarter. • X4 Pharmaceuticals (NASDAQ: XFOR ) is projected to report quarterly loss at $0.61 per share on revenue of $120.00 thousand. • First Industrial Realty (NYSE: FR ) is projected to report earnings for its first quarter. • Berkshire Grey (NASDAQ: BGRY ) is estimated to report quarterly loss at $0.13 per share on revenue of $4.23 million. • Matinas BioPharma Hldgs (AMEX: MTNB ) is likely to report earnings for its first quarter. • KT (NYSE: KT ) is likely to report earnings for its first quarter. • Crescent Point Energy (NYSE: CPG ) is projected to report quarterly earnings at $0.25 per share on revenue of $693.53 million. • ironSource (NYSE: IS ) is estimated to report quarterly earnings at $0.03 per share on revenue of $183.58 million. • Aemetis (NASDAQ: AMTX ) is expected to report earnings for its first quarter.
NICE (NICE) is scheduled to announce Q1 earnings results on Thursday, May 12th, before market open.The consensus EPS Estimate is $1.71 (+11.0% Y/Y) and the consensus Revenue Estimate…
If you''re a trend trader, consider that the strongest clear trend on the hourly chart exists on the 20 hour timeframe. The post NICE Ltd (NICE): Price Now Near $273.14; Daily Chart Shows An Uptrend on 100 Day Basis appeared first on ETF Daily News .
Philadelphia chose NICE Ltd''s (NASDAQ: NICE ) NICE Inform Elite& to boost emergency communications for its new 911 center slated to open in 2022. NICE''s 911-ready technology will help to improve the center''s operational Full story available on Benzinga.com
Upgrades According to Deutsche Bank, the prior rating for KLA Corp (NASDAQ: KLAC ) was changed from Hold to Buy. KLA earned $3.85 in the third quarter, compared to $2.47 in the year-ago quarter. The current stock performance of KLA shows a 52-week-high of $359.69 and a 52-week-low of $171.31. Moreover, at the end of the last trading period, the closing price was at $313.80. According to JP Morgan, the prior rating for NICE Ltd (NASDAQ: NICE ) was changed from Neutral to Overweight. NICE earned $1.54 in the first quarter, compared to $1.34 in the year-ago quarter. The stock has a 52-week-high of $288.73 and a 52-week-low of $181.76. At the end of the last trading period, NICE closed at $218.92. Credit Suisse upgraded the previous rating for Colgate-Palmolive Co (NYSE: CL ) from Neutral to Outperform. In the first quarter, Colgate-Palmolive showed an EPS of $0.80, compared to $0.75 from the year-ago quarter. The stock has a 52-week-high of $86.41 and a 52-week-low of $71.21. At the end of the last trading period, Colgate-Palmolive closed at $82.93.
If you''re a trend trader, consider that the strongest clear trend on the hourly chart exists on the 50 hour timeframe. The post NICE Ltd (NICE): Price Now Near $215.52; Daily Chart Shows Downtrend on 20 Day Basis appeared first on ETF Daily News .
NICE Ltd (NASDAQ: NICE ) and RingCentral Inc (NYSE: RNG ) have extended their multi-year agreement to market and sell RingCentral Contact Center globally to tap the … Full story available on Benzinga.com
NICE earnings call for the period ending March 31, 2021.
RA`ANANA, Israel (AP) _ Nice Ltd. (NICE) on Thursday reported first-quarter profit of $52.2 million. The Ra`Anana, Israel-based company said it had profit of 78 cents per share. Earnings, adjusted for one-time gains and costs, were $1.54 per share. The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment []
Analysts expect that NICE Ltd. (NASDAQ:NICE) will post earnings per share of $1.38 for the current quarter, Zacks reports. Four analysts have provided estimates for NICE’s earnings, with the lowest EPS estimate coming in at $1.36 and the highest estimate coming in at $1.40. NICE posted earnings of $1.30 per share during the same quarter […]
NICE Ltd. (NASDAQ:NICE) has earned a consensus rating of “Hold” from the eleven ratings firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective […]
HOBOKEN, N.J.--(BUSINESS WIRE)--NICE Ltd. (NASDAQ: NICE) (the "Company") announced today that it intends to offer, subject to market and other considerations, $400,000,000 aggregate principal amount of Convertible Senior Notes due 2025 (the "Convertible Notes") in a private placement under the Securities Act of 1933, as amended (the "Securities Act"). The Company also intends to grant to the initial purchasers of the Convertible Notes an option to purchase up to an additional $60,000,000 aggreg
The National Institute for Health and Care Excellence (NICE) last week warned that pills including paracetamol, should no longer be routinely prescribed to patients with chronic pain.
According to a new study, aspirin, ibuprofen and paracetamol, common painkillers we are used to taking for mild fever or aches and pains, may cause more harm than good in the treatment of chronic pain. In a draft guideline published on Monday, Aug. 3, the United Kingdom's National Institute for Health and Care Excellence (Nice) announced that there is "little or no evidence" of the efficacy of commonly used medicines against primary chronic pain, which is defined as pain that lasts or reappears for longer than three months and is caused by physical incapacity or emotional distress. According to the announcement, analgesics don't diminish pain, improve quality of life or minimiz… Keep on reading: Common painkillers should not be used for chronic pain, study suggests
Painkillers such as paracetamol, ibuprofen, aspirin and opioids can do “more harm than good” and should not be prescribed to treat chronic pain, health officials have said. The National Institute for Health and Care Excellence (Nice) said that there was “little or no evidence” the commonly used drugs for chronic primary pain made any difference to people’s quality of life,
Nice say paracetamol, ibuprofen and opioids should not be prescribed for chronic pain Painkillers such as paracetamol, ibuprofen, aspirin and opioids can do “more harm than good” and should not be prescribed to treat chronic pain, health officials have said. The National Institute for Health and Care Excellence (Nice) said there was “little or no evidence” the commonly used drugs for chronic primary pain made any difference to people’s quality of life, pain or psychological distress. Continue reading…
There is 'little or no evidence' the commonly used drugs work, according to England's health regulators, the National Institute for Health and Care Excellence (Nice).
People with chronic pain that can’t be explained by other conditions should not be prescribed opioids because they do more harm than good, the medicines watchdog has warned. The National Institute for Health and Care Excellence (NICE) has said people should instead be offered group exercise, acupuncture and psychological therapy. In new draft guidance, NICE said most of the
Domino's Pizza came under fire this week after launching a promotional offer in Australia and New Zealand that promised to give all "nice, law-abiding Karens" a free pizza. The free giveaway posted to the pizza chain's Australia and New Zealand social media pages immediately received backlash. Some accused it of "rewarding privilege" and ignoring more important issues. Domino's New Zealand has since apologized and said it has dropped the promotion. The Australian promotion is still running. Visit Business Insider's homepage for more stories . Domino's in New Zealand ditched a promotional offer that promised to give all "nice, law-abiding Karens" a free pizza after receiving backlash online. Earlier this week, the pizza chain's Australia and New Zealand social media pages said they wanted to reclaim the name after it became a meme used to describe middle-aged white women who like to complain. "Karen" incidents often involve racism as well. The giveaway was titled "Calling all (nice) Karens" and asked anyone who is named "Karen" to fill in a form that tells the pizza chain in 250 words why they were one of the "nice ones" in order to receive a free pizza.
Taking vitamin D supplements does not help prevent or treat Covid-19, health officials have said. Officials from the National Institute for Health and Care Excellence (Nice) launched a rapid review of evidence in response to claims that the vitamin could reduce the risk of acute respiratory tract infections and Covid-19.
NHS watchdog the National Institute for Health and Care Excellence (NICE) reviewed studies into vitamin D and Covid-19 and found no evidence it protects people.
Nice (NICE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
DUBLIN--(BUSINESS WIRE)--The "Global Physical Security Information Management (PSIM) Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The physical security information management (PSIM) market is poised to grow by $ 2.59 bn during 2020-2024 progressing at a CAGR of 21% during the forecast period. This report on the physical security information management (PSIM) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as
NICE's (NICE) first-quarter 2020 results benefit from robust cloud revenues and an expanding customer base despite the coronavirus headwind.
New guidelines have been issued to the NHS by the National Institute for Health and Care Excellence (NICE)
The new guidelines were published by the National Institute for Health and Care Excellence (NICE), which provides guidelines to the NHS
SALT LAKE CITY--(BUSINESS WIRE)--NICE inContact (Nasdaq: NICE) the leader in cloud contact center solutions, today announced rapid expansion across more than 300 government and non-profit sectors to support increased demand. The NICE inContact CXone cloud customer experience platform enables organizations of all sizes to quickly transition contact center agents to work from home, dynamically move calls across locations and handle significantly increased volumes of calls or digital interactions
The National Institute for Health and Care Excellence (NICE) have now issued an update
HOBOKEN, N.J.--(BUSINESS WIRE)--NICE Actimize, a NICE business (Nasdaq: NICE) and leader in Autonomous Financial Crime Management, today announced that two new partners offering unique financial crime fighting solutions have joined its X-Sight Marketplace, the first financial crime and compliance ecosystem that connects financial services organizations with data, applications, tools and service providers, providing both the value of choice and the ability to reduce integration timelines. The ne
HOBOKEN, N.J.--(BUSINESS WIRE)--NICE (Nasdaq: NICE) today announced CXone@home, a limited time offering to support organizations in their challenging time, as they respond to COVID-19. CXone@home cloud native offering is designed to enable contact centers to transition their workforce to work-from-home in 48 hours or less. CXone@home is also available to organizations with on-premises infrastructure that still do not use CXone and enables expediting their response to COVID-19. CXone@home is off
Britain's National Institute for Health and Care Excellence (NICE), the advisor to the National Health Service (NHS) on costs and care quality, has recomme
HOBOKEN, N.J.--(BUSINESS WIRE)--NICE (Nasdaq: NICE) today announced Ibotta, one of the most frequently used shopping apps in the United States, has selected NICE Workforce Management and NICE Employee Engagement Manager in the cloud to offer flexibility and control to their part-time and remote employees. As a company whose workforce is growing at a double-digit rate, Ibotta needed a solution that not only addressed the scheduling needs of their mobile workforce but also offered employees the c
SALT LAKE CITY--(BUSINESS WIRE)-- #COVID--NICE inContact (Nasdaq: NICE) today announced expanded support for contact centers to eliminate potential disruptions during the current COVID-19 outbreak. NICE inContact is providing a free work-from-home module for users of the NICE inContact CXone cloud customer experience platform, to maintain service continuity while employees need to work from home. In addition, to support the potential increase in call volume that 211 and 311 organizations may receive, NI
HOBOKEN, N.J.--(BUSINESS WIRE)-- #Engagement--NICE (Nasdaq: NICE) today announced its recognition as a Leader in Gartner’s Magic Quadrant for Workforce Engagement Management1 report for the fourth consecutive year. NICE is positioned again this year with the highest position on the 'Completeness of Vision' and furthest position on the 'Ability to Execute' axes, respectively. Issued on February 20, the report recognizes NICE as a Leader. NICE is the only vendor to be named a Leader by Gartner across both thei
Nice Actimize, a Nice (Nasdaq: NICE) business and the leader in Autonomous Financial Crime Management, has been chosen by Tonik, a leading Southeast Asi…
HOBOKEN, N.J.--(BUSINESS WIRE)--NICE Actimize, a NICE business (Nasdaq: NICE) and leader in Autonomous Financial Crime Management, today announced that it has added two new partners offering significant anti-money laundering and data intelligence capabilities to its X-Sight Marketplace, the first financial crime and compliance ecosystem that connects financial services organizations with data, applications, tools and service providers, providing both the value of choice and the ability to reduc
HOBOKEN, N.J.--(BUSINESS WIRE)--NICE (NASDAQ: NICE) today announced results for the fourth quarter and full year ended December 31, 2019. Full Year 2019 Financial Highlights GAAP Non-GAAP Record revenue of $1,574 million, growth of 9% year-over-year Record revenue of $1,577 million, growth of 9% year-over-year Cloud revenue of $596 million, growth of 29% year-over-year Cloud revenue of $599 million, growth of 28% year-over-year Gross margin of 66.2% compared to 65.6% last year Gross margin of 7
- ← Previous
- 1
- 2
- Next →